TMDC FET Biosensors for Low-Cost Single-Molecule Detection

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current nanofabrication techniques are inadequate for producing affordable, high-quality biosensor chips using one-dimensional nanostructures like nanowires and carbon nanotubes, which are necessary for sensitive biomarker detection, due to high processing costs and lack of efficient top-down planar nanofabrication processes.

Innovation Solution

The development of biosensors using two-dimensional atomically layered materials such as transition metal dichalcogenides (TMDCs) like molybdenum disulfide, which offer sensitive electrical responses and low noise levels, integrated with a field-effect transistor (FET) structure, including a monolayer channel, an insulating layer, and a reservoir layer for fluidic channels, to enable precise biomolecule interaction quantification.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Measurement precision

If nanowire or carbon nanotube FET biosensors are used to achieve fM-level detection sensitivity, then measurement precision is improved, but manufacturing cost and device complexity increase due to expensive bottom-up synthesis and lack of top-down nanofabrication processes

Engineering Contradiction:
Improvedetection sensitivityVSAvoidmanufacturing cost
Core Design Contradiction:
Measurement precisionVSEase of manufacture

Solution Approach 1:

The patent transitions from one-dimensional nanowire/CNT channels to two-dimensional atomically thin layer channels, changing the dimensional parameter of the sensing material. This enables compatibility with planar nanofabrication processes while maintaining the critical thin-channel dimension needed for high detection sensitivity, thus resolving the contradiction between measurement precision and ease of manufacture

Inventive Principle:
Principle #35Parameter changes

Solution Approach 2:

By enabling planar nanofabrication of 2D material FETs, the patent makes biosensor chips more suitable for disposable applications. The simplified manufacturing process using standard planar techniques reduces costs enough to justify single-use biosensor chips, eliminating the need for expensive reusable nanowire/CNT devices

Inventive Principle:
Principle #27Cheap short-living objects (Disposable)

2Measurement precision

If nanowire or carbon nanotube FET biosensors are used to achieve fM-level detection sensitivity, then measurement precision is improved, but device complexity increases due to exquisite nanolithographic tools and semiconductor-on-insulator substrates

Engineering Contradiction:
Improvedetection sensitivityVSAvoidfabrication process complexity
Core Design Contradiction:
Measurement precisionVSDevice complexity

Solution Approach 1:

The patent changes the material dimensionality parameter from 1D nanowires/CNTs to 2D atomically thin layers, which fundamentally simplifies the fabrication approach. Two-dimensional materials can be processed using standard planar nanofabrication techniques rather than requiring complex three-dimensional nanowire manipulation or carbon nanotube alignment, thus reducing device complexity while preserving the thin-channel dimension for high sensitivity

Inventive Principle:
Principle #35Parameter changes

Solution Approach 2:

The patent explicitly transitions from one-dimensional nanochannels to two-dimensional atomically thin layer channels. This dimensional change enables the use of planar nanofabrication processes, simplifying the overall device structure and fabrication steps while maintaining the critical thin dimension needed for high detection sensitivity

Inventive Principle:
Principle #17Another dimension (Dimensionality change)

3Measurement precision

If atomically thin 2D layer channels are used in FET biosensors, then measurement precision is improved through enhanced sensitivity to external stimuli, but manufacturing precision requirements increase for achieving consistent monolayer quality

Engineering Contradiction:
Improvesensor response sensitivityVSAvoidmonolayer quality consistency
Core Design Contradiction:
Measurement precisionVSManufacturing precision

Solution Approach 1:

The patent employs planar nanofabrication processes that are already well-established in the semiconductor industry for creating two-dimensional material FETs. These universal processes, adapted from standard CMOS fabrication, provide consistent control over monolayer quality and device parameters, enabling reproducible manufacturing of high-sensitivity biosensors without requiring new or specialized manufacturing techniques

Inventive Principle:
Principle #6Universality (Multi-functionality)

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

This approach allows for cost-effective manufacturing of biosensors with high detection sensitivity, achieving limits of detection as low as 60 fM for biomarkers, and enables consistent calibration of sensor responses across multiple devices, enhancing the precision of biomarker concentration quantification and interaction kinetics analysis.

Implementation Method 1

field-effect transistor (FET) structure... sensitive electrical responses to antigen-antibody binding events

Methodology Applied
Scientific EffectField effect: Electric Field

Data Source

PatentUS9678037B2Two-dimensional material-based field-effect transistor sensors
Publication Date: 2017.06.13 THE RGT UNIV OF MICHIGAN
  • US9678037B2 patent drawing
  • US9678037B2 patent drawing
  • US9678037B2 patent drawing

AI summary

Atomically layered transition metal dichalcogenides (TMDCs) exhibit a significant potential to enable low-cost transistor biosensors that permit single-molecule-level quantification of biomolecules. Two different principles for operating such biosensors are presented. In one arrangement, antibody receptors are functionalized on an insulating layer deposited onto the channel of the transistor. The charge introduced through antigen-antibody binding is capacitively coupled with the channel and shifts the threshold voltage without significantly changing the transconductance. In another arrangement, antibodies are functionalized directly on the channel of the transistor. Antigen-antibody binding events mainly modulate the ON-state transconductance, which is attributed to the disordered potential formed in channel material.